Eris Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

341.30

324.41

409.71

411.29

314.58

Operating profit

79.39

74.43

144.49

155.50

111.49

Interest

28.89

15.14

6.55

6.84

2.96

Gross profit

70.89

62.73

144.92

152.69

112.79

EPS (Rs)

2.90

2.33

8.66

8.14

6.46

Other income

20.39

3.43

6.98

4.03

4.26

Stock adjustment

10.40

4.65

-2.95

-25.25

-6.06

Raw material

17.74

23.75

28.64

26.17

25.07

Power and fuel

-

-

-

-

-

Employee expenses

79.52

80.69

81.10

90.36

60.63

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

154.25

140.90

158.44

164.50

123.45

Provisions made

-

-

-

-

-

Depreciation

29.14

28.08

25.00

20.16

17.28

Taxation

2.24

2.99

2.11

21.78

7.67

Net profit / loss

39.51

31.66

117.81

110.74

87.84

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.60

13.60

13.60

13.60

13.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

23.26

22.94

35.27

37.81

35.44

GPM (%)

19.60

19.13

34.78

36.76

35.38

NPM (%)

10.92

9.66

28.27

26.66

27.55